Market Analysis and Insights: Global Transmucosal Drug Delivery Market
The global Transmucosal Drug Delivery market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Transmucosal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Transmucosal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Transmucosal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Transmucosal Drug Delivery include 3M Pharmaceuticals, Acrux Limited, ALZA Corporation, Antares Pharma, Inc., Apricus BioSciences, Inc, Aveva Drug Delivery Systems, Corium International, Inc, DURECT Corporation and Generex Biotechnology Corporation, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Transmucosal Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Transmucosal Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transmucosal Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transmucosal Drug Delivery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Transmucosal Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Transmucosal Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 3M Pharmaceuticals, Acrux Limited, ALZA Corporation, Antares Pharma, Inc., Apricus BioSciences, Inc, Aveva Drug Delivery Systems, Corium International, Inc, DURECT Corporation and Generex Biotechnology Corporation, etc.
By Company
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Segment by Type
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Transmucosal Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transmucosal Drug Delivery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transmucosal Drug Delivery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2018-2029)
2.2 Global Transmucosal Drug Delivery Growth Trends by Region
2.2.1 Transmucosal Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transmucosal Drug Delivery Historic Market Size by Region (2018-2023)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Region (2024-2029)
2.3 Transmucosal Drug Delivery Market Dynamics
2.3.1 Transmucosal Drug Delivery Industry Trends
2.3.2 Transmucosal Drug Delivery Market Drivers
2.3.3 Transmucosal Drug Delivery Market Challenges
2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transmucosal Drug Delivery by Players
3.1.1 Global Transmucosal Drug Delivery Revenue by Players (2018-2023)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transmucosal Drug Delivery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2022
3.5 Global Key Players of Transmucosal Drug Delivery Head office and Area Served
3.6 Global Key Players of Transmucosal Drug Delivery, Product and Application
3.7 Global Key Players of Transmucosal Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2018-2023)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2024-2029)
5 Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2018-2023)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2018-2029)
6.2 North America Transmucosal Drug Delivery Market Size by Type
6.2.1 North America Transmucosal Drug Delivery Market Size by Type (2018-2023)
6.2.2 North America Transmucosal Drug Delivery Market Size by Type (2024-2029)
6.2.3 North America Transmucosal Drug Delivery Market Share by Type (2018-2029)
6.3 North America Transmucosal Drug Delivery Market Size by Application
6.3.1 North America Transmucosal Drug Delivery Market Size by Application (2018-2023)
6.3.2 North America Transmucosal Drug Delivery Market Size by Application (2024-2029)
6.3.3 North America Transmucosal Drug Delivery Market Share by Application (2018-2029)
6.4 North America Transmucosal Drug Delivery Market Size by Country
6.4.1 North America Transmucosal Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Transmucosal Drug Delivery Market Size by Country (2018-2023)
6.4.3 North America Transmucosal Drug Delivery Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2018-2029)
7.2 Europe Transmucosal Drug Delivery Market Size by Type
7.2.1 Europe Transmucosal Drug Delivery Market Size by Type (2018-2023)
7.2.2 Europe Transmucosal Drug Delivery Market Size by Type (2024-2029)
7.2.3 Europe Transmucosal Drug Delivery Market Share by Type (2018-2029)
7.3 Europe Transmucosal Drug Delivery Market Size by Application
7.3.1 Europe Transmucosal Drug Delivery Market Size by Application (2018-2023)
7.3.2 Europe Transmucosal Drug Delivery Market Size by Application (2024-2029)
7.3.3 Europe Transmucosal Drug Delivery Market Share by Application (2018-2029)
7.4 Europe Transmucosal Drug Delivery Market Size by Country
7.4.1 Europe Transmucosal Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Transmucosal Drug Delivery Market Size by Country (2018-2023)
7.4.3 Europe Transmucosal Drug Delivery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transmucosal Drug Delivery Market Size (2018-2029)
8.2 China Transmucosal Drug Delivery Market Size by Type
8.2.1 China Transmucosal Drug Delivery Market Size by Type (2018-2023)
8.2.2 China Transmucosal Drug Delivery Market Size by Type (2024-2029)
8.2.3 China Transmucosal Drug Delivery Market Share by Type (2018-2029)
8.3 China Transmucosal Drug Delivery Market Size by Application
8.3.1 China Transmucosal Drug Delivery Market Size by Application (2018-2023)
8.3.2 China Transmucosal Drug Delivery Market Size by Application (2024-2029)
8.3.3 China Transmucosal Drug Delivery Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Transmucosal Drug Delivery Market Size (2018-2029)
9.2 Asia Transmucosal Drug Delivery Market Size by Type
9.2.1 Asia Transmucosal Drug Delivery Market Size by Type (2018-2023)
9.2.2 Asia Transmucosal Drug Delivery Market Size by Type (2024-2029)
9.2.3 Asia Transmucosal Drug Delivery Market Share by Type (2018-2029)
9.3 Asia Transmucosal Drug Delivery Market Size by Application
9.3.1 Asia Transmucosal Drug Delivery Market Size by Application (2018-2023)
9.3.2 Asia Transmucosal Drug Delivery Market Size by Application (2024-2029)
9.3.3 Asia Transmucosal Drug Delivery Market Share by Application (2018-2029)
9.4 Asia Transmucosal Drug Delivery Market Size by Region
9.4.1 Asia Transmucosal Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Transmucosal Drug Delivery Market Size by Region (2018-2023)
9.4.3 Asia Transmucosal Drug Delivery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Details
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.1.5 3M Pharmaceuticals Recent Developments
11.2 Acrux Limited
11.2.1 Acrux Limited Company Details
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.2.5 Acrux Limited Recent Developments
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Details
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.3.5 ALZA Corporation Recent Developments
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Details
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.4.5 Antares Pharma, Inc. Recent Developments
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Details
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.5.5 Apricus BioSciences, Inc Recent Developments
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Details
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.6.5 Aveva Drug Delivery Systems Recent Developments
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Details
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.7.5 Corium International, Inc Recent Developments
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Details
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.8.5 DURECT Corporation Recent Developments
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Details
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.9.5 Generex Biotechnology Corporation Recent Developments
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Details
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.10.5 Inovio Pharmaceuticals, Inc. Recent Developments
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Details
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.12.5 MedPharm LTD Recent Developments
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Details
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.13.5 Mylan, Inc. Recent Developments
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Details
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.14.5 Nemaura Pharma Ltd Recent Developments
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Details
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.15.5 Nitto Denko Corporation Recent Developments
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Details
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.16.5 Noven Pharmaceuticals, Inc. Recent Developments
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Details
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.17.5 Pantec Biosolutions AG Recent Developments
11.18 Tapemark
11.18.1 Tapemark Company Details
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Introduction
11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.18.5 Tapemark Recent Developments
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Details
11.19.2 tesa Labtec GmbH Business Overview
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
11.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.19.5 tesa Labtec GmbH Recent Developments
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Details
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2018-2023)
11.21.5 Zosano Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
*If Applicable.